Target intelligence / Profile preview

E3 Ubiquitin-Protein Ligase Parkin (Parkin)

Target
Parkin
Molecular classification
Enzyme, E3 ubiquitin ligase, RBR-type E3 ubiquitin ligase
01

Overview

E3 Ubiquitin-Protein Ligase Parkin is a key enzyme involved in the ubiquitin-proteasome system and mitochondrial quality control. As an E3 ubiquitin ligase, it facilitates the attachment of ubiquitin to target proteins, marking them for degradation or other cellular processes like mitophagy. Mutations in the PRKN gene, which encodes parkin, are a major cause of early-onset Parkinson's disease, highlighting its critical role in neuronal survival and function.

Other names
PRKNPARK2
02

Mechanism of action

Not applicable, target is an enzyme and there are no commonly known drugs that directly target it. Research efforts are underway to develop parkin activators or modulators.

03

Biological functions

UbiquitinationProtein degradationMitophagyProtein quality controlRegulation of apoptosis
04

Disease associations

Neurodegenerative diseaseParkinson's disease
05

Safety considerations

Developing selective parkin activators/modulators that do not disrupt other ubiquitin ligase pathways is a significant challenge.Potential off-target effects due to the broad substrate specificity of parkin.

Beyond the preview

Go deeper on E3 Ubiquitin-Protein Ligase Parkin (Parkin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 Ubiquitin-Protein Ligase Parkin (Parkin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call